Electrophysiological Effects of Potential QT Prolonging Drugs
Conditions: Drug-induced QT Prolongation; Pharmacokinetics; Pharmacodynamics Interventions: Drug: Clarithromycin; Drug: Pimozide; Drug: Placebo (Part 1); Drug: Moxifloxacin; Drug: Cobicistat; Drug: Moxifloxacin and Cobicistat; Drug: Placebo (Part 2) Sponsors: Food and Drug Administration (FDA); Spaulding Clinical Research LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2023 Category: Research Source Type: clinical trials
Electrophysiological Effects of Potential QT Prolonging Drugs
Conditions: Drug-induced QT Prolongation; Pharmacokinetics; Pharmacodynamics Interventions: Drug: Clarithromycin; Drug: Pimozide; Drug: Placebo; Drug: Moxifloxacin; Drug: Cobicistat; Drug: Moxifloxacin and Cobicistat Sponsors: Food and Drug Administration (FDA); Spaulding Clinical Research LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2023 Category: Research Source Type: clinical trials
Thorough QT/QTc of Pritelivir in Healthy Subjects
Condition: HSV Infection Interventions: Drug: Pritelivir and moxifloxacin placebo; Drug: Pritelivir placebo, moxifloxacin and moxifloxacin placebo; Drug: Pritelivir placebo, moxifloxacin placebo and moxifloxacin Sponsor: AiCuris Anti-infective Cures AG Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2023 Category: Research Source Type: clinical trials